NCT00021021View on ClinicalTrials.gov

RPI.4610 in Treating Patients With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 2001

Study Completion Date

February 29, 2004

Conditions

Kidney Cancer

Interventions

BIOLOGICAL

anti-FLT-1 ribozyme

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors

lead

Ribozyome

INDUSTRY

NCT00021021 - RPI.4610 in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter